hotspot -WSS

hotspot

author：Wikipedia 2025-09-28 23:11:30 - browse：71842

This image provided by Novo Nordisk in January 2023, shows packaging for the company's Wegovy drug. — Novo Nordisk via AP

PHILADELPHIA — Novo Nordisk’s obesity drug Wegovy notably cut the risk of heart attacks in a landmark cardiovascular trial that affirms the treatment offers health benefits beyond weight loss.

The company in August had announced that in this trial, called Select, Wegovy reduced the overall rate of major heart problems — heart attacks, stroke, or cardiovascular-related death — by 20%. That finding, which was the primary outcome the trial set out to study, was stronger than many were expecting and led Novo’s stock to surge.

But details of the study, including risk reductions for each specific heart complication, were not released until Saturday, when they were presented here — before a standing-room only crowd — as the first major session of the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： A common UTI test for kids haunts adults as a traumatic 'nightmare'

knowledge

explore

WSS

Walmart eyes Medicare Advantage provider ChenMed

WATCH: Why do bright lights make us see spots?

Pig kidney works a record two months in donated body

FDA proposes changes to key medical devices approval pathway

Manchin plays down potential 3rd

Flagship, Pfizer team up in deal worth up to $7 billion

Wikipedia

hotspot

focus

Novavax promises a turnaround & Lilly roils the obesity market

How housing is health care on Long Island

As demand for Covid shots wanes, Moderna seeks its next success

15 die by electrocution after transformer explodes in northern India

Drug repurposing or repositioning? The language matters

Twill hunts for pharma partner to market its depression app

New air purifier tech could be key to improving indoor air quality

White House touts steps to stem shortages of cancer treatments

Guidelines to prevent youth baseball injuries need more muscle

Hospitals consider fixing cancer drug shortages on their own

entertainment

Private equity could exacerbate cardiology's overuse problem, experts fear

FDA approves updated Covid vaccines

Asa Hutchinson previews new plan to reform federal law enforcement if elected in 2024

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

A Theranos scientist

Study: Hearing aids may slow cognitive decline in those at risk

explore

knowledge

explore

leisure time